Diligence memo · auto-generated · as of July 2, 2026
Full Genomes Corp
Full Genomes Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Full Genomes Corp operates in Other Technology, based in ROCKVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Full Genomes Corp has raised $538K in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $250K on 2013-09-05.
Most recent recorded round closed around 2014-12-09.
Valuation (modeled)modeled
Provath models Full Genomes Corp at approximately $8.0M (range $123K–$90M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.55× the median modeled value of Pre-Seed Other Technology companies in 2013–2015 (1452 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 11.6 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 19% of Other Technology peers (21302 compared).
Modeled value ranks above 19% of those peers.
Closest niche peers: OrbitHCI, Inc., Via Response Technologies, Inc., Compendium Software Llc, Access Media Corp., Chronos Tech LLC.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.